PAVmed (PAVM) Accumulated Expenses (2015 - 2025)

PAVmed's Accumulated Expenses history runs 11 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• On a quarterly basis, Accumulated Expenses fell 51.97% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 51.97% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 51.97% from the prior year.
• Accumulated Expenses fell to $2.5 million in Q4 2025 per PAVM's latest filing, from $2.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $6.8 million in Q2 2024 and bottomed at $1.1 million in Q1 2021.
• The 5-year median for Accumulated Expenses is $3.2 million (2022), against an average of $3.6 million.
• Across the five-year window, Accumulated Expenses soared 208.74% in 2022 and plunged 65.69% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $4.3 million in 2021, then retreated by 13.01% to $3.7 million in 2022, then jumped by 78.84% to $6.6 million in 2023, then dropped by 21.88% to $5.2 million in 2024, then tumbled by 51.97% to $2.5 million in 2025.
• Per Business Quant, the three latest PAVM Accumulated Expenses figures stand at $2.5 million (Q4 2025), $2.7 million (Q3 2025), and $2.8 million (Q2 2025).